|
ARIH2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
5.05628872105035E-12 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
3.651400E-01 |
| Stage1-vs-Stage3 |
1.39340000004928E-06 |
| Stage1-vs-Stage4 |
9.202800E-03 |
| Stage2-vs-Stage3 |
4.339600E-02 |
| Stage2-vs-Stage4 |
2.677000E-01 |
| Stage3-vs-Stage4 |
3.831200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.28980000013712E-08 |
| Normal-vs-Asian |
2.709600E-01 |
| Caucasian-vs-AfricanAmerican |
6.348000E-02 |
| Caucasian-vs-Asian |
4.759500E-03 |
| AfricanAmerican-vs-Asian |
7.876400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.291400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.97650001815464E-09 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.89190893454361E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.745800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.847800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.919600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.052000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.120000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.165200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.586600E-04 |
| Normal-vs-Grade 2 |
1.11022302462516E-16 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.6269208202857E-12 |
| Grade 1-vs-Grade 2 |
3.561600E-01 |
| Grade 1-vs-Grade 3 |
2.578200E-02 |
| Grade 1-vs-Grade 4 |
9.239900E-02 |
| Grade 2-vs-Grade 3 |
1.943150E-03 |
| Grade 2-vs-Grade 4 |
5.114300E-02 |
| Grade 3-vs-Grade 4 |
9.230600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
2.22044604925031E-16 |
| ccA subtype-vs-ccB subtype |
7.442400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
2.52480000240141E-08 |
| N0-vs-N1 |
3.867800E-01 |
|
|
